Elevated ET-1 levels could also independently predict clinical worsening in IPAH patients treated with Bosentan, and ET-1 played a crucial role in vascular and tissue fibrosis [19, 20]. Here, EDN1 is linked to idiopathic pulmonary arterial hypertension.